Early left ventricular abnormalities in children with heterozygous familial hypercholesterolemia

Giovanni Di Salvo1, Angelo Fabio D'Aiello, Biagio Castaldi

  • 1Second University of Naples, Monaldi Hospital, Via Omodeo 45, Naples, Italy. giodisal@yahoo.it

Insights

Children with familial hypercholesterolemia (FH) show early cardiac changes, including thicker left ventricular walls and altered myocardial function, despite normal ejection fractions. These preclinical effects highlight the impact of high cholesterol in childhood.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Imaging
  • Genetic Lipid Disorders

Background:

  • Limited data exist on cardiac morphology and function in children with heterozygous familial hypercholesterolemia (FH).
  • FH offers a unique model to study pure hypercholesterolemia's cardiac effects, free from comorbidities.
  • Speckle-tracking echocardiography enables detailed assessment of myocardial deformation.

Purpose of the Study:

  • To investigate the preclinical effects of isolated hypercholesterolemia on cardiovascular structure and function in children with FH.
  • To utilize speckle-tracking echocardiography to assess left ventricular (LV) function in these children.

Main Methods:

  • Prospective study of 90 children (45 with FH, 45 controls), mean age 11 ± 3 years.
  • Echocardiography with speckle-tracking to evaluate LV morphology and myocardial deformation.

Main Results:

  • Children with FH exhibited increased LV wall thickness and LV mass.
  • Diastolic function was impaired in FH children, indicated by prolonged deceleration times and reduced early diastolic velocities.
  • Longitudinal and circumferential LV myocardial strain were significantly reduced, while radial strain increased, despite normal LV ejection fractions.

Conclusions:

  • Hypercholesterolemia in childhood is linked to significant alterations in LV morphology and function.
  • Reductions in longitudinal/circumferential strain appear compensated by increased radial strain in FH children with normal ejection fractions.
  • Further long-term studies are needed to clarify the clinical significance and optimal treatment strategies for cholesterol-lowering therapy in young FH patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...